Detalhe da pesquisa
1.
Polo-like Kinase 1 as a potential therapeutic target in Diffuse Intrinsic Pontine Glioma.
BMC Cancer
; 16: 647, 2016 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27538997
2.
Unraveling the Complexity of the Senescence-Associated Secretory Phenotype in Adamantinomatous Craniopharyngioma Using Multi-Modal Machine Learning Analysis.
Neuro Oncol
; 2024 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38334125
3.
Uncertainty-Aware Deep Learning Classification of Adamantinomatous Craniopharyngioma from Preoperative MRI.
Diagnostics (Basel)
; 13(6)2023 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36980440
4.
Multi-omic approach identifies hypoxic tumor-associated myeloid cells that drive immunobiology of high-risk pediatric ependymoma.
iScience
; 26(9): 107585, 2023 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37694144
5.
Adamantinomatous craniopharyngioma associated with a compromised blood-brain barrier: patient series.
J Neurosurg Case Lessons
; 1(19): CASE2150, 2021 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35854837
6.
Robust deep learning classification of adamantinomatous craniopharyngioma from limited preoperative radiographic images.
Sci Rep
; 10(1): 16885, 2020 10 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33037266
7.
Establishment of patient-derived orthotopic xenograft model of 1q+ posterior fossa group A ependymoma.
Neuro Oncol
; 21(12): 1540-1551, 2019 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31276586
8.
Preclinical analysis of MTOR complex 1/2 inhibition in diffuse intrinsic pontine glioma.
Oncol Rep
; 39(2): 455-464, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29207163
9.
Characterization of 2 Novel Ependymoma Cell Lines With Chromosome 1q Gain Derived From Posterior Fossa Tumors of Childhood.
J Neuropathol Exp Neurol
; 76(7): 595-604, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28863455
10.
Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastoma.
Oncotarget
; 7(33): 53881-53894, 2016 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27449089